{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:43:38Z","timestamp":1782254618066,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T00:00:00Z","timestamp":1400630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s13277-014-2059-x","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T21:22:22Z","timestamp":1400620942000},"page":"8149-8159","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pathological and prognostic significance of hypoxia-inducible factor 1\u03b1 expression in epithelial ovarian cancer: a meta-analysis"],"prefix":"10.1007","volume":"35","author":[{"given":"Yue","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,21]]},"reference":[{"issue":"6","key":"2059_CR1","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/sj.bjc.6601186","volume":"89","author":"T Kurokawa","year":"2003","unstructured":"Kurokawa T, Miyamoto M, Kato K, Cho Y, Kawarada Y, Hida Y, et al. Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer. 2003;89(6):1042\u20137.","journal-title":"Br J Cancer"},{"issue":"3\u20134","key":"2059_CR2","first-page":"293","volume":"23","author":"QT Le","year":"2004","unstructured":"Le QT, Denko NC, Giaccia AJ. Hypoxic gene expression and metastasis. Cancer Metastasis Rev. 2004;23(3\u20134):293\u2013310.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"2059_CR3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1006\/bbrc.1999.1889","volume":"266","author":"DE Richard","year":"1999","unstructured":"Richard DE, Berra E, Pouyssegur J. Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun. 1999;266(3):718\u201322.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"2059_CR4","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995;92(12):5510\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2059_CR5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1172\/JCI0214105","volume":"109","author":"P Vajkoczy","year":"2002","unstructured":"Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, et al. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest. 2002;109(6):777\u201385.","journal-title":"J Clin Invest"},{"issue":"22","key":"2059_CR6","first-page":"5830","volume":"59","author":"H Zhong","year":"1999","unstructured":"Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999;59(22):5830\u20135.","journal-title":"Cancer Res"},{"issue":"4","key":"2059_CR7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1469-185X.1996.tb01283.x","volume":"71","author":"WJ Murdoch","year":"1996","unstructured":"Murdoch WJ. Ovarian surface epithelium, ovulation and carcinogenesis. Biol Rev Camb Philos Soc. 1996;71(4):529\u201343.","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"9","key":"2059_CR8","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.humpath.2007.02.010","volume":"38","author":"R Osada","year":"2007","unstructured":"Osada R, Horiuchi A, Kikuchi N, Yoshida J, Hayashi A, Ota M, et al. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel\u2013Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel\u2013Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. Hum Pathol. 2007;38(9):1310\u201320.","journal-title":"Hum Pathol"},{"issue":"6","key":"2059_CR9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00404-008-0816-z","volume":"279","author":"M Miyazawa","year":"2009","unstructured":"Miyazawa M, Yasuda M, Fujita M, Hirasawa T, Kajiwara H, Hirabayashi K, et al. Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1. Arch Gynecol Obstet. 2009;279(6):789\u201396.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"2059_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2007.03.041","volume":"106","author":"S Lee","year":"2007","unstructured":"Lee S, Garner EI, Welch WR, Berkowitz RS, Mok SC. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma. Gynecol Oncol. 2007;106(2):311\u20137.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2059_CR11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ygyno.2003.08.022","volume":"91","author":"C Wong","year":"2003","unstructured":"Wong C, Wellman TL, Lounsbury KM. VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer. Gynecol Oncol. 2003;91(3):513\u20137.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"2059_CR12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00404-007-0500-8","volume":"277","author":"T Iida","year":"2008","unstructured":"Iida T, Yasuda M, Miyazawa M, Fujita M, Osamura RY, Hirasawa T, et al. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha\/GLUT-1 expression. Arch Gynecol Obstet. 2008;277(6):539\u201346.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"2059_CR13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1525-1438.2007.01055.x","volume":"18","author":"R Shimogai","year":"2008","unstructured":"Shimogai R, Kigawa J, Itamochi H, Iba T, Kanamori Y, Oishi T, et al. Expression of hypoxia-inducible factor 1alpha gene affects the outcome in patients with ovarian cancer. Int J Gynecol Cancer. 2008;18(3):499\u2013505.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"2059_CR14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2006.11.017","volume":"251","author":"H Nakai","year":"2007","unstructured":"Nakai H, Watanabe Y, Ueda H, Hoshiai H. Hypoxia inducible factor 1-alpha expression as a factor predictive of efficacy of taxane\/platinum chemotherapy in advanced primary epithelial ovarian cancer. Cancer Lett. 2007;251(1):164\u20137.","journal-title":"Cancer Lett"},{"issue":"6","key":"2059_CR15","first-page":"1661","volume":"7","author":"P Birner","year":"2001","unstructured":"Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res. 2001;7(6):1661\u20138.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2059_CR16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cdp.2007.01.001","volume":"31","author":"E Konac","year":"2007","unstructured":"Konac E, Onen HI, Metindir J, Alp E, Biri AA, Ekmekci A. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers. Cancer Detect Prev. 2007;31(2):102\u20139.","journal-title":"Cancer Detect Prev"},{"issue":"2","key":"2059_CR17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bcp.2007.04.003","volume":"74","author":"MC Duyndam","year":"2007","unstructured":"Duyndam MC, van Berkel MP, Dorsman JC, Rockx DA, Pinedo HM, Boven E. Cisplatin and doxorubicin repress vascular endothelial growth factor expression and differentially down-regulate hypoxia-inducible factor I activity in human ovarian cancer cells. Biochem Pharmacol. 2007;74(2):191\u2013201.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"2059_CR18","first-page":"107","volume":"1755","author":"JI Bardos","year":"2005","unstructured":"Bardos JI, Ashcroft M. Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta. 2005;1755(2):107\u201320.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2059_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ctrv.2006.05.003","volume":"32","author":"JL O\u2019Donnell","year":"2006","unstructured":"O\u2019Donnell JL, Joyce MR, Shannon AM, Harmey J, Geraghty J, Bouchier-Hayes D. Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression. Cancer Treat Rev. 2006;32(6):407\u201316.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"2059_CR20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.critrevonc.2010.05.003","volume":"78","author":"LM Seeber","year":"2011","unstructured":"Seeber LM, Horree N, Vooijs MA, Heintz AP, van der Wall E, Verheijen RH, et al. The role of hypoxia inducible factor-1alpha in gynecological cancer. Crit Rev Oncol Hematol. 2011;78(3):173\u201384.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"2059_CR21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejso.2004.03.008","volume":"30","author":"M Quintero","year":"2004","unstructured":"Quintero M, Mackenzie N, Brennan PA. Hypoxia-inducible factor 1 (HIF-1) in cancer. Eur J Surg Oncol. 2004;30(5):465\u20138.","journal-title":"Eur J Surg Oncol"},{"issue":"Suppl 1","key":"2059_CR22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1525-1438.2006.00310.x","volume":"16","author":"H Jiang","year":"2006","unstructured":"Jiang H, Feng Y. Hypoxia-inducible factor 1alpha (HIF-1alpha) correlated with tumor growth and apoptosis in ovarian cancer. Int J Gynecol Cancer. 2006;16 Suppl 1:405\u201312.","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"2059_CR23","doi-asserted-by":"crossref","first-page":"13264","DOI":"10.3390\/ijms131013264","volume":"13","author":"Y Chen","year":"2012","unstructured":"Chen Y, Zhang L, Pan Y, Ren XB, Hao Q. Over-expression of semaphorin4D, hypoxia-inducible factor-1 alpha and vascular endothelial growth factor is related to poor prognosis in ovarian epithelial cancer. Int J Mol Sci. 2012;13(10):13264\u201374.","journal-title":"Int J Mol Sci"},{"key":"2059_CR24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/1471-2407-8-335","volume":"8","author":"A Daponte","year":"2008","unstructured":"Daponte A, Ioannou M, Mylonis I, Simos G, Minas M, Messinis IE, et al. Prognostic significance of hypoxia-inducible factor 1 alpha(HIF-1 alpha) expression in serous ovarian cancer: an immunohistochemical study. BMC Cancer. 2008;8:335.","journal-title":"BMC Cancer"},{"issue":"5","key":"2059_CR25","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3892\/ijo.2013.1878","volume":"42","author":"F Ji","year":"2013","unstructured":"Ji F, Wang Y, Qiu L, Li S, Zhu J, Liang Z, et al. Hypoxia inducible factor 1alpha-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer. Int J Oncol. 2013;42(5):1578\u201388.","journal-title":"Int J Oncol"},{"issue":"2","key":"2059_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3835(01)00762-5","volume":"176","author":"K Nakayama","year":"2002","unstructured":"Nakayama K, Kanzak A, Hata K, Katabuchi H, Okamura H, Miyazaki K, et al. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma. Cancer Lett. 2002;176(2):215\u201323.","journal-title":"Cancer Lett"},{"issue":"1","key":"2059_CR27","first-page":"111","volume":"19","author":"M Yasuda","year":"2008","unstructured":"Yasuda M, Miyazawa M, Fujita M, Kajiwara H, Iida T, Hirasawa T, et al. Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character. Oncol Rep. 2008;19(1):111\u20136.","journal-title":"Oncol Rep"},{"issue":"1","key":"2059_CR28","first-page":"38","volume":"40","author":"J Luo","year":"2005","unstructured":"Luo J, Peng Z, Yang K, Wang H, Yang H, Dong D, et al. Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray. Zhonghua Fu Chan Ke Za Zhi. 2005;40(1):38\u201341.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"4","key":"2059_CR29","first-page":"361","volume":"25","author":"SY Li","year":"2009","unstructured":"Li SY, Yang WW, Wen QT, Xu L, Meng HM, Chen M, et al. Expression and significance of HIF-1alpha and PTEN in epithelial ovarian carcinoma and their correlation. Chin J Clin Exp Pathol. 2009;25(4):361\u20133.","journal-title":"Chin J Clin Exp Pathol"},{"issue":"2","key":"2059_CR30","first-page":"83","volume":"20","author":"M Su","year":"2011","unstructured":"Su M, Zhang Y, Huang H. Expression of HIF-1alpha and MMP-2 in vasculogenic mimicry of ovarian cancer. Curr Adv Obstet Gynecol. 2011;20(2):83\u20137.","journal-title":"Curr Adv Obstet Gynecol"},{"issue":"5","key":"2059_CR31","first-page":"272","volume":"35","author":"XG Tong","year":"2008","unstructured":"Tong XG, Xu HM, Liu YP, Hou KZ. Role of hypoxia-inducible factor-1alpha(HIF-1alpha) and angiogenic factors in peritoneal metastases and prognosis of advanced serous ovarian cancer. Chin J Clin Oncol. 2008;35(5):272\u20136.","journal-title":"Chin J Clin Oncol"},{"issue":"6","key":"2059_CR32","first-page":"657","volume":"64","author":"L Yu","year":"2012","unstructured":"Yu L, Wu S, Zhou L, Song W. Correlation between bacterial L-form infection, expression of HIF-1alpha\/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer. Sheng Li Xue Bao. 2012;64(6):657\u201365.","journal-title":"Sheng Li Xue Bao"},{"issue":"10","key":"2059_CR33","first-page":"786","volume":"46","author":"Y Chen","year":"2011","unstructured":"Chen Y, Zhang L, Liu X. The expression and clinical significance of semaphorin4D, hypoxia-inducible factor-1\u03b1 and vascular endothelial growth factor in ovarian epithelial cancer. Chin J Obstet Gynecol. 2011;46(10):786\u20138.","journal-title":"Chin J Obstet Gynecol"},{"key":"2059_CR34","first-page":"1373","volume":"11","author":"L Fu","year":"2008","unstructured":"Fu L, Feng W, Zhao YH, Wang AH, Wang BB, Yang LX, et al. Expression and significance of hypoxia inducible factor-la in ovarian epithelial cancer. Chin J Lab Diagn. 2008;11:1373\u20135.","journal-title":"Chin J Lab Diagn"},{"key":"2059_CR35","first-page":"421","volume":"04","author":"LL Guo","year":"2010","unstructured":"Guo LL, Liu ZQ, Zhang LP, Guo GL. Expression and clinical significance of human leucocyte antigen protein G and hypoxia inducible factor-l\u03b1 in epithelial ovarian carcinoma. J Hainan Med Univ. 2010;04:421\u2013,8.","journal-title":"J Hainan Med Univ"},{"key":"2059_CR36","first-page":"507","volume":"04","author":"GL Li","year":"2011","unstructured":"Li GL, Wang Z, Han RF. Expression of mitogen activated protein kinase p38 and hypoxia-inducible factor la in epithefial ovarian cancer. Clin Med Eng. 2011;04:507\u20139.","journal-title":"Clin Med Eng"},{"key":"2059_CR37","first-page":"276","volume":"02","author":"LX Liu","year":"2012","unstructured":"Liu LX, Liu GM, Sun YH, He XP. Analysis of the relationship between HIF-1\u0430 gene expression and drug resistance of chemotherapy in ovarian cancer. Progress Modern Biomed. 2012;02:276\u20139.","journal-title":"Progress Modern Biomed"},{"key":"2059_CR38","first-page":"383","volume":"05","author":"Y Shen","year":"2013","unstructured":"Shen Y, Zhang XY, Shi YQ, Wang Y, Guo DH. Significance of Glut-1, HIF-1 and P53 expression in ovarian cancer. J Tianjin Med Univ. 2013;05:383\u20136,437.","journal-title":"J Tianjin Med Univ"},{"key":"2059_CR39","first-page":"4795","volume":"20","author":"XC Wang","year":"2008","unstructured":"Wang XC, Li XY, Li SQ. Expression of HIF-1A and VEGF and their relationship in ovarian neoplasms. Chin J Misdiagn. 2008;20:4795\u20137.","journal-title":"Chin J Misdiagn"},{"key":"2059_CR40","first-page":"207","volume":"03","author":"J Yu","year":"2009","unstructured":"Yu J, Huang YC, Zhang LJ, Lu YB. Expression and significance of hypoxia-inducible factor-1\u03b1 and glucose transporter protein-1 in epithelial ovarian tumor. Chin Clin Oncol. 2009;03:207\u201311.","journal-title":"Chin Clin Oncol"},{"issue":"4","key":"2059_CR41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0895-4356(03)00011-8","volume":"56","author":"J Attia","year":"2003","unstructured":"Attia J, Thakkinstian A, D\u2019Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56(4):297\u2013303.","journal-title":"J Clin Epidemiol"},{"key":"2059_CR42","first-page":"w13518","volume":"142","author":"AJ Nordmann","year":"2012","unstructured":"Nordmann AJ, Kasenda B, Briel M. Meta-analyses: what they can and cannot do. Swiss Med Wkly. 2012;142:w13518.","journal-title":"Swiss Med Wkly"},{"key":"2059_CR43","first-page":"w13855","volume":"143","author":"W Ren","year":"2013","unstructured":"Ren W, Mi D, Yang K, Cao N, Tian J, Li Z, et al. The expression of hypoxia-inducible factor-1alpha and its clinical significance in lung cancer: a systematic review and meta-analysis. Swiss Med Wkly. 2013;143:w13855.","journal-title":"Swiss Med Wkly"},{"issue":"10","key":"2059_CR44","first-page":"801","volume":"50","author":"PJ Diest van","year":"1997","unstructured":"van Diest PJ, van Dam P, Henzen-Logmans SC, Berns E, van der Burg ME, Green J, et al. A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. Eur Organ Res Treat Cancer-Gynaecol Cancer Coop Group J Clin Pathol. 1997;50(10):801\u20134.","journal-title":"Eur Organ Res Treat Cancer-Gynaecol Cancer Coop Group J Clin Pathol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2059-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2059-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2059-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T17:11:20Z","timestamp":1565457080000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2059-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,21]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2059"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2059-x","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,21]]}}}